Table 2.

Treatment-associated Changes (mean ± SD) in Fasting Lipid and Lipoprotein Concentrations Within Each Experimental Group

Variable	Fenofibrate (n=12)			Rosiglitazone (n=12)			Calorie-Restricted Diet (n=13)
	Before	After	p	Before	After	p	Before	After	p
Triglycerides (mg/dl)	231 ± 117	140 ± 47	0.001	209 ± 67	232 ± 72	0.63	201 ± 121	143 ± 49	0.01
High-density lipoprotein cholesterol (mg/dl)	35 ± 7	36 ± 8	0.10	40 ± 11	42 ± 13	0.10	38 ± 9	38 ± 7	0.91
Total cholesterol (mg/dl)	191 ± 33	173 ± 23	0.03	203 ± 43	217 ± 41	0.07	216 ± 39	194 ± 44	<0.001
Low-density lipoprotein cholesterol (mg/dl)	114 ± 34	111 ± 22	0.72	119 ± 41	129 ± 37	0.18	144 ± 34	128 ± 34	0.01

Within each experimental group, before and after means were compared by Student’s paired t-test.